Previous Page  3 / 22 Next Page
Information
Show Menu
Previous Page 3 / 22 Next Page
Page Background

Page 39

J u l y 2 3 - 2 4 , 2 0 1 8 | R o m e , I t a l y

allied

academies

Joint Event on

Cardiology Congress 2018 & Microbe Infection 2018

Biomedical Research

|

ISSN: 0976-1683

|

Volume 29

2

nd

World Congress on

CARDIOLOGY

MICROBIOLOGY AND MICROBIAL INFECTION

&

39

th

Annual Congress on

Grzegorz Bereta et al., Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C1-003

GENETIC VARIABILITY OF PEPTIDYL

ARGININE DEIMINASE FROM

PORPHYROMONAS GINGIVALIS

IN

PERIODONTITIS PATIENTS

Grzegorz Bereta

1

, K Gawron

1

, Z Nowakowska

1

, K Łazarz-Barty-

zel

1

, M Chomyszyn-Gajewska

1

and

J Potempa

1,2

1

Jagiellonian University, Poland

2

University of Louisville School of Dentistry, USA

Introduction & Objective:

Periodontitis is a widespread chronic inflammatory

disease. Untreated condition leads to progressive destruction of the

periodontal tissue and may result in tooth loss. Changes in oral microbiome

leading to periodontitis are mainly driven by

Porphyromonas gingivalis

, the

pathogen producing numerous virulence factors, including peptidylarginine

deiminase (PPAD). PPAD modifies C-terminal arginine to citrulline, causing

changes in structure and function of modified proteins, contributing to

development periodontitis. The aim of this study was to investigate variability

of PPAD in clinical isolates of

P. gingivalis

.

Materials & Methods:

Together 23

P. gingivalis

strains were isolated from

patients with periodontitis and the PPAD gene was sequenced and analyzed

together with sequences extracted from the GenBank database. Identified

differences in the sequence were introduced into PPAD in reference strain

ATCC 33277 and expression (mRNA) and PPAD activity were measured in

cultures of the mutant. PPAD variants were expressed in

P. gingivalis

, purified

and used to compare their enzymatic properties. Clinical parameters of

periodontitis severity in patients infected with different

P. gingivalis

strains

were determined.

Results:

A new form of PPAD with three amino acid substitutions (G231N,

E232T, N235D) near the active site was found in approximately 30% of

P.

gingivalis

strains. Introduction of those mutations into the PPAD sequence

in the ATCC 33277 strain resulted in two-fold increase of PPAD activity in

culture, without effect on the level of mRNA expression. Kinetic assessment

of the enzymatic reaction revealed that the mutated form of PPAD had higher

maximum reaction rate (V

max

). Patients infected with

P. gingivalis

strains with

the super active PPAD variant had more advanced damage of periodontal

tissues.

Conclusion:

The newly identified form of PPAD shows higher enzymatic

activity and its presence in strains of

P. gingivalis

in periodontitis patients

correlated with severity of the disease.

Grzegorz Bereta has completed his MSc in Molecular

Biotechnology at Faculty of Biochemistry, Biophysics

and Biotechnology, Jagiellonian University, Krakow,

Poland and since then he is enrolled on PhD studies at

the same faculty. He has authored two publications and

two conference reports as well as one book chapter.

tnghd337@naver.com

BIOGRAPHY